Puma Complete Spectana

The newest entry of the Puma supportive top line running range is the Complete Spectana. Based on a new comfort last and Puma's own unique M2D supportive system, the Complete Spectana offers great cushioning and support for your daily running needs. (Updated Model : Puma Complete Spectana 2)

MSRP : US$135
Weight : 13.3 oz / 377 gm
Predecessor : Nil
Product Cycle : RY.2010.DY.2010.Dec.
Features : duoCell®, IdCell®, M2D+™ , EverFoam™, KMS Lite, ArchTec™, OrthoLite Sockliner, EverTrack™, EverRide

View Similar ShoesRatingFlag-C5S4

Recommended for runners with normal to low arches looking for a supportive high-end stability and highly cushioned shoe.
PumaCompleteSpectanaMPumaCompleteSpectanaW
History : Complete Spectana Series : Spectana('10)


ZebarPlusGlossry

ArchTec™ : Midfoot support system used to reinforce the arch and offer torsional stability.

duoCell® : Specifically engineeredHexagonal duoCELL pattern is anatomically positioned to provide durable cushioning and maximum stability. The Cell layers, made of elastomer, greatly reduce the impact forces upon heel strike. The independent Cells support a natural foot motion and slow the foot's inward rotation for optimized foot strike.

EverFoam™ : Special slow-recovery foam heel construction for a heel fit which perfectly adjusts to the heel contour.

EverRide™ : Blown rubber formulation.

EverTrack™ : High abrasion-resistant rubber composite outsole material placed in areas of high-wear.

IdCell® : Cushioning low density material for improved shock absorption. The anatomically specific placement is designed to protect and support during the gait cycle.

KMS Lite : Midsole material is 30% lighter than standard PUMA-EVA and reduces the overall shoe weight up to 10%.

M2D+™ : Located at the medial midsole and is designed to slow the rate of pronation while being 30% lighter than the original M2D material.

OrthoLite Sockliner : Consists of two layers for maximum fit and comfort and fast material regeneration. Designed for optimized air circulation.


No comments: